Amyotrophic lateral sclerosis

@article{Es2017AmyotrophicLS,
  title={Amyotrophic lateral sclerosis},
  author={M. V. Es and O. Hardiman and A. Chi{\`o} and A. Al-Chalabi and L. Berg},
  journal={The Lancet},
  year={2017},
  volume={390},
  pages={2084-2098}
}
  • M. V. Es, O. Hardiman, +2 authors L. Berg
  • Published 2017
  • Medicine
  • The Lancet
    • Amyotrophic lateral sclerosis is characterised by the progressive loss of motor neurons in the brain and spinal cord. This neurodegenerative syndrome shares pathobiological features with frontotemporal dementia and, indeed, many patients show features of both diseases. Many different genes and pathophysiological processes contribute to the disease, and it will be necessary to understand this heterogeneity to find effective treatments. In this Seminar, we discuss clinical and diagnostic… CONTINUE READING
    View on Elsevier
    eprints.whiterose.ac.uk
    18 Citations
    Highly Influencial Citations
    2
    Background Citations
    12

    Supplemental Presentations

    PRESENTATION SLIDES
    Amyotrophic lateral sclerosis
    Explore Further
    Discover more papers related to the topics discussed in this paper

    Figures, Tables, and Topics from this paper.

    Figures and Tables

    Explore Further: Topics Discussed in This Paper

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients
    Given the role of adaptive immunity in ALS, the pathogenicity of some clostridial strains on motorneurons, the putative role of cyanobacteria in ALS development, and the increasing… Expand
    ConditionsAmyotrophic Lateral Sclerosis
    InterventionBiological
    Azienda Ospedaliero-Universitaria di Modena
    February 2019 - February 2022
    INTERVENTIONAL CLINICAL TRIAL
    Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial
    The purpose of this research is to investigate the validity of a previous clinical trial named EH301, which showed beneficial effects of anti-oxidant therapies in patients with… Expand
    ConditionsAmyotrophic Lateral Sclerosis (ALS)
    InterventionCombination Product
    Dallas VA Medical Center
    February 2020 - December 2021
    OBSERVATIONAL CLINICAL TRIAL
    Salivary Biomarker Discovery by Raman Spectroscopy in ALS (SalivALS)
    BACKGROUND/RATIONALE: The paucity of biomarkers for the diagnosis and monitoring of patients affected by Amyotrophic Lateral Sclerosis (ALS) is one of the greatest concerns in ALS… Expand
    ConditionsAmyotrophic Lateral Sclerosis
    InterventionProcedure
    Fondazione Don Carlo Gnocchi Onlus
    July 2019 - July 2020
    BLOG POST
    BioID : enquête au cœur du CellFest
    Café des sciences
    8 February 2019
    18 Citations
    Citation Type

    Citation Type

    Novel therapeutic targets for amyotrophic lateral sclerosis
    • 2
    Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study
    • 2
    Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis.
    • 10
    Respiratory complications of amyotrophic lateral sclerosis
    • 3
    • PDF
    Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches
    • 16
    • PDF
    Adipsin, MIP-1b, and IL-8 as CSF Biomarker Panels for ALS Diagnosis
    • 4
    • PDF
    Radial diffusivity as an imaging biomarker for early diagnosis of non-demented amyotrophic lateral sclerosis
    • 3
    ALS-Associated SOD1(G93A) Decreases SERCA Pump Levels and Increases Store-Operated Ca2+ Entry in Primary Spinal Cord Astrocytes from a Transgenic Mouse Model
    • 3
    • PDF
    Neuroglia in Neurodegenerative Diseases
    • 1
    Meta-analysis of the association between ZNF512B polymorphism rs2275294 and risk of amyotrophic lateral sclerosis
    • 3

    References

    SHOWING 1-10 OF 271 REFERENCES
    Energy metabolism in amyotrophic lateral sclerosis
    • 340
    Amyotrophic lateral sclerosis: moving towards a new classification system
    • 161
    State of play in amyotrophic lateral sclerosis genetics
    • 980
    • PDF
    A mutation in sigma‐1 receptor causes juvenile amyotrophic lateral sclerosis
    • 293
    ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
    • 595
    Gene discovery in amyotrophic lateral sclerosis: implications for clinical management
    • 132
    • PDF
    TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
    • 1,288
    Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis
    • 66
    Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis
    • 476
    • PDF
    Mutations of optineurin in amyotrophic lateral sclerosis
    • 958